{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:17:39Z","timestamp":1787883459714,"version":"build-2784847793"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Biotechnology, Government of India","award":["DBT\/2021-22\/IISER-TVM\/1748"],"award-info":[{"award-number":["DBT\/2021-22\/IISER-TVM\/1748"]}]},{"DOI":"10.13039\/100008487","name":"Cure Parkinson's Trust","doi-asserted-by":"publisher","award":["PT01"],"award-info":[{"award-number":["PT01"]}],"id":[{"id":"10.13039\/100008487","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SRG\/2021\/000981"],"award-info":[{"award-number":["SRG\/2021\/000981"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009053","name":"Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/E\/17\/1\/503664"],"award-info":[{"award-number":["IA\/E\/17\/1\/503664"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06157-4","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:55:53Z","timestamp":1787882153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chlorogenic Acid Fails to Confer Neuroprotection in a Chronic Mouse Model of Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"63","author":[{"given":"Akshaya","family":"Rajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surya","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"6157_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J,\u00a0Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primer 3:1\u201321. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Parkinson disease. Nat Rev Dis Primer"},{"key":"6157_CR2","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin D, Zhang YP, Lobanova E, Miller A, Li X, Xia Z,\u00a0Dakin H, Sideris DI et al (2022) Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease. Nat Commun 13:5512. https:\/\/doi.org\/10.1038\/s41467-022-33252-6","journal-title":"Nat Commun"},{"key":"6157_CR3","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","volume":"35","author":"GE Gillies","year":"2014","unstructured":"Gillies GE, Pienaar IS, Vohra S, Qamhawi Z (2014) Sex differences in Parkinson\u2019s disease Front Neuroendocrinol 35:370\u2013384. https:\/\/doi.org\/10.1016\/j.yfrne.2014.02.002","journal-title":"Sex differences in Parkinson\u2019s disease Front Neuroendocrinol"},{"key":"6157_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Elbaz A, Nichols E, Abbasi N, Abd-Allah F, Abdelalim A,\u00a0Adsuar JC, Ansha MG et al (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"6157_CR5","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.3233\/JPD-230354","volume":"14","author":"P Mahlknecht","year":"2024","unstructured":"Mahlknecht P, Poewe W (2024) Pharmacotherapy for disease modification in early Parkinson\u2019s disease: how early should we be? J Parkinsons Dis 14:S407\u2013S421. https:\/\/doi.org\/10.3233\/JPD-230354","journal-title":"J Parkinsons Dis"},{"key":"6157_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ncl.2019.12.002","volume":"38","author":"P Poewe","year":"2020","unstructured":"Poewe P, Mahlknecht P (2020) Pharmacologic treatment of motor symptoms associated with Parkinson disease. Neurol Clin 38:255\u2013267. https:\/\/doi.org\/10.1016\/j.ncl.2019.12.002","journal-title":"Neurol Clin"},{"issue":"7","key":"6157_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/1028415X.2022.2073107","volume":"26","author":"VE Bianchi","year":"2023","unstructured":"Bianchi VE, Rizzi L, Somaa F (2023) The role of nutrition on Parkinson\u2019s disease: a systematic review. Nutr Neurosci 26(7):605\u2013628. https:\/\/doi.org\/10.1080\/1028415X.2022.2073107","journal-title":"Nutr Neurosci"},{"key":"6157_CR8","doi-asserted-by":"publisher","unstructured":"Talebi S, Ghoreishy SM, Jayedi A, Travica N, Mohammadi H (2022) Dietary antioxidants and risk of Parkinson\u2019s disease: a systematic review and dose-response meta-analysis of observational studies. Adv Nutr Bethesda Md 13:1493\u20131504.\u00a0\u00a0https:\/\/doi.org\/10.1093\/advances\/nmac001","DOI":"10.1093\/advances\/nmac001"},{"key":"6157_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ana.1052","volume":"50","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Zhang SM, Hern\u00e1n MA, Kawachi I, Colditz GA, Speizer FE,\u00a0Willett WC\u00a0(2001) Prospective study of caffeine consumption and risk of Parkinson\u2019s disease in men and women. Ann Neurol 50:56\u201363. https:\/\/doi.org\/10.1002\/ana.1052","journal-title":"Ann Neurol"},{"key":"6157_CR10","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3390\/nu12061860","volume":"12","author":"CT Hong","year":"2020","unstructured":"Hong CT, Chan L, Bai C-H (2020) The effect of caffeine on the risk and progression of Parkinson\u2019s disease: a meta-analysis. Nutrients 12:1860. https:\/\/doi.org\/10.3390\/nu12061860","journal-title":"Nutrients"},{"key":"6157_CR11","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/WNL.0000000000004568","volume":"89","author":"RB Postuma","year":"2017","unstructured":"Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D,\u00a0Furtado S, Munhoz RP\u00a0et al (2017) Caffeine as symptomatic treatment for Parkinson disease (Caf\u00e9-PD): a randomized trial. Neurology 89:1795\u20131803. https:\/\/doi.org\/10.1212\/WNL.0000000000004568","journal-title":"Neurology"},{"issue":"3130","key":"6157_CR12","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1111\/1541-4337.12620","volume":"19","author":"H Lu","year":"2020","unstructured":"Lu H, Tian Z, Cui Y, Liu Z, Ma X (2020) Chlorogenic acid: a comprehensive review of the dietary sources, processing effects, bioavailability, beneficial properties, mechanisms of action, and future directions. Compr Rev Food Sci Food Saf 19(3130):3158. https:\/\/doi.org\/10.1111\/1541-4337.12620","journal-title":"Compr Rev Food Sci Food Saf"},{"key":"6157_CR13","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.3390\/molecules26247502","volume":"26","author":"S Awwad","year":"2021","unstructured":"Awwad S, Issa R, Alnsour L, Albals D, Al-Momani I (2021) Quantification of caffeine and chlorogenic acid in green and roasted coffee samples using HPLC-DAD and evaluation of the effect of degree of roasting on their levels. Molecules 26:7502. https:\/\/doi.org\/10.3390\/molecules26247502","journal-title":"Molecules"},{"key":"6157_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.biopha.2017.10.064","volume":"97","author":"M Naveed","year":"2018","unstructured":"Naveed M, Hejazi V, Abbas M, Kamboh AA, Khan GJ, Shumzaid M, Ahmad F, Babazadeh D et al (2018) Chlorogenic acid (CGA): a pharmacological review and call for further research. Biomed Pharmacother 97:67\u201374. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.064","journal-title":"Biomed Pharmacother"},{"key":"6157_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jep.2012.04.010","volume":"142","author":"S-H Kwon","year":"2012","unstructured":"Kwon S-H, Kim M-J, Ma S-X, You I-J, Hwang J-Y, Oh J-H, Kim SY, Kim HC et al (2012) Eucommia ulmoides Oliv. Bark. protects against hydrogen peroxide-induced neuronal cell death in SH-SY5Y cells. J Ethnopharmacol 142:337\u2013345. https:\/\/doi.org\/10.1016\/j.jep.2012.04.010","journal-title":"J Ethnopharmacol"},{"key":"6157_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102410","volume":"57","author":"T Zhou","year":"2025","unstructured":"Zhou T, Zhang J (2025) Therapeutic advances and application of PARP inhibitors in breast cancer. Transl Oncol 57:102410. https:\/\/doi.org\/10.1016\/j.tranon.2025.102410","journal-title":"Transl Oncol"},{"key":"6157_CR17","doi-asserted-by":"publisher","unstructured":"David KK, Andrabi SA, Dawson TM, Dawson VL (2009) Parthanatos, a messenger of death. Front Biosci Ed 14: 1116\u201328.\u00a0\u00a0https:\/\/doi.org\/10.2741\/3297","DOI":"10.2741\/3297"},{"key":"6157_CR18","doi-asserted-by":"publisher","unstructured":"Kim H, Park J, Kang H, Yun SP, Lee Y-S, Lee Y-I, Lee Y (2020) Activation of the Akt1-CREB pathway promotes RNF146 expression to inhibit PARP1-mediated neuronal death. Sci Signal 13:eaax7119.\u00a0https:\/\/doi.org\/10.1126\/scisignal.aax7119","DOI":"10.1126\/scisignal.aax7119"},{"key":"6157_CR19","doi-asserted-by":"publisher","unstructured":"Kam T-I, Mao X, Park H, Chou S-C, Karuppagounder SS, Umanah GE, Yun SP, Brahmachari S et al (2018) Poly(ADP-ribose) drives pathologic \u03b1-synuclein neurodegeneration in Parkinson\u2019s disease. Science 362:eaat8407.\u00a0https:\/\/doi.org\/10.1126\/science.aat8407","DOI":"10.1126\/science.aat8407"},{"key":"6157_CR20","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1007\/s12035-022-03005-z","volume":"59","author":"N Sharma","year":"2022","unstructured":"Sharma N, Soni R, Sharma M, Chatterjee S, Parihar N, Mukarram M, Kale R, Sayyed AA et al (2022) Chlorogenic acid: a polyphenol from coffee rendered neuroprotection against rotenone-induced Parkinson\u2019s disease by GLP-1 secretion. Mol Neurobiol 59:6834\u201356. https:\/\/doi.org\/10.1007\/s12035-022-03005-z","journal-title":"Mol Neurobiol"},{"key":"6157_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11064-025-04356-4","volume":"50","author":"A Cantero-T\u00e9llez","year":"2025","unstructured":"Cantero-T\u00e9llez A, Moreno-Fierros L, Guti\u00e9rrez-Ospina G, Santiago-Prieto AC, Ju\u00e1rez I, Rodr\u00edguez-Sosa M, Hern\u00e1ndez-Echeagaray E (2025) Systemic neuroprotection by chlorogenic acid: antioxidant and anti-inflammatory evaluation in early neurodegeneration induced by 3-nitropropionic acid in mice. Neurochem Res 50:113. https:\/\/doi.org\/10.1007\/s11064-025-04356-4","journal-title":"Neurochem Res"},{"key":"6157_CR22","doi-asserted-by":"publisher","unstructured":"Wang L, Wang X, Hou L, Liu Y, Liu J, Zhang D, Yao S, Zheng D (2025) Protective effect of chlorogenic acid on cognitive impairment in rats with early Alzheimer\u2019s disease via Wnt signaling pathway. J Alzheimers Dis Rep 9:25424823251315848.\u00a0\u00a0https:\/\/doi.org\/10.1177\/25424823251315848","DOI":"10.1177\/25424823251315848"},{"key":"6157_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1089\/jmf.2017.0110","volume":"21","author":"LY Zu\u00f1iga","year":"2018","unstructured":"Zu\u00f1iga LY, Aceves-de la Mora MCA, Gonz\u00e1lez-Ortiz M, Ramos-N\u00fa\u00f1ez JL, Mart\u00ednezAbundis E (2018) Effect of chlorogenic acid administration on glycemic control, insulin secretion, and insulin sensitivity in patients with impaired glucose tolerance. J Med Food 21:469\u201373. https:\/\/doi.org\/10.1089\/jmf.2017.0110","journal-title":"J Med Food"},{"key":"6157_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","volume":"133","author":"A Anandhan","year":"2017","unstructured":"Anandhan A, Jacome MS, Lei S, Hernandez-Franco P, Pappa A, Panayiotidis MI, Powers R, Franco R (2017) Metabolic dysfunction in Parkinson\u2019s disease: bioenergetics, redox homeostasis and central carbon metabolism. Brain Res Bull 133:12\u201330. https:\/\/doi.org\/10.1016\/j.brainresbull.2017.03.009","journal-title":"Brain Res Bull"},{"key":"6157_CR25","doi-asserted-by":"publisher","unstructured":"Li H, Zeng F, Huang C, Pu Q, Thomas ER, Chen Y, Li X (2024) The potential role of glucose metabolism, lipid metabolism, and amino acid metabolism in the treatment of Parkinson\u2019s disease. CNS Neurosci Ther. 30:e14411.\u00a0https:\/\/doi.org\/10.1111\/cns.14411","DOI":"10.1111\/cns.14411"},{"key":"6157_CR26","doi-asserted-by":"publisher","unstructured":"Gao X, Zhang B, Zheng Y, Liu X, Rostyslav P, Finiuk N, Sik A, Stoika R\u00a0et al (2023) Neuroprotective effect of chlorogenic acid on Parkinson\u2019s disease like symptoms through boosting the autophagy in zebrafish. Eur J Pharmacol 956:17595010.\u00a0\u00a0https:\/\/doi.org\/10.1016\/j.ejphar.2023.175950","DOI":"10.1016\/j.ejphar.2023.175950"},{"key":"6157_CR27","doi-asserted-by":"publisher","unstructured":"Perumalsamy SA, Kadal KK, Viswanathan G, Ramasamy K (2025) Evaluation of chlorogenic acid in Parkinson\u2019s disease model: an in-vitro study in 6-OHDA induced SH-SY5Y cell line. J Clin Diagn Res.\u00a0 \u00a0https:\/\/doi.org\/10.7860\/JCDR\/2025\/78862.21047","DOI":"10.7860\/JCDR\/2025\/78862.21047"},{"key":"6157_CR28","doi-asserted-by":"publisher","unstructured":"Singh SS, Rai SN, Birla H, Zahra W, Kumar G, Gedda MR, Tiwari N, Patnaik R\u00a0et al (2018) Effect of chlorogenic acid supplementation in MPTP-intoxicated mouse. Front Pharmacol 9:757.\u00a0\u00a0https:\/\/doi.org\/10.3389\/fphar.2018.00757","DOI":"10.3389\/fphar.2018.00757"},{"key":"6157_CR29","doi-asserted-by":"publisher","unstructured":"He C-L, Tang Y, Wu J-M, Long T, Yu L, Teng J-F, Qiu WQ, Pan R\u00a0et al (2023) Chlorogenic acid delays the progression of Parkinson\u2019s disease via autophagy induction in Caenorhabditis elegans. Nutr Neurosci 26:11\u201324. https:\/\/doi.org\/10.1080\/1028415X.2021.2009993","DOI":"10.1080\/1028415X.2021.2009993"},{"key":"6157_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/ph16020178","volume":"16","author":"C Bai","year":"2023","unstructured":"Bai C, Zhou X, Yu L, Wu A, Yang L, Chen J, Tang X, Zou W et al (2023) A rapid and sensitive UHPLC-MS\/MS method for determination of chlorogenic acid and its application to distribution and neuroprotection in rat brain. Pharmaceuticals (Basel) 16:178. https:\/\/doi.org\/10.3390\/ph16020178","journal-title":"Pharmaceuticals (Basel)"},{"key":"6157_CR31","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1021\/acs.jafc.0c01554","volume":"68","author":"L Li","year":"2020","unstructured":"Li L, Su C, Chen X, Wang Q, Jiao W, Luo H, Tang J, Wang W et al (2020) Chlorogenic acids in cardiovascular disease: a review of dietary consumption, pharmacology, and pharmacokinetics. J Agric Food Chem 68:6464\u201384. https:\/\/doi.org\/10.1021\/acs.jafc.0c01554","journal-title":"J Agric Food Chem"},{"key":"6157_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104623","volume":"134","author":"C Mezias","year":"2020","unstructured":"Mezias C, Rey N, Brundin P, Raj A (2020) Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: involvement of retrograde and anterograde axonal propagation. Neurobiol Dis 134:104623. https:\/\/doi.org\/10.1016\/j.nbd.2019.104623","journal-title":"Neurobiol Dis"},{"key":"6157_CR33","doi-asserted-by":"publisher","unstructured":"Vaidya B, Dhamija K, Guru P, Sharma SS (2021) Parkinson\u2019s disease in women: mechanisms underlying sex differences.\u00a0 Eur J Pharmacol 895:173862.\u00a0https:\/\/doi.org\/10.1016\/j.ejphar.2021.173862","DOI":"10.1016\/j.ejphar.2021.173862"},{"key":"6157_CR34","doi-asserted-by":"publisher","unstructured":"Ferreira SA, Li C, Kl\u00e6strup IH, Vitic Z, Rasmussen RK, Kirkegaard A, Toft GU, Betzer C\u00a0et al (2023) Sex-dimorphic neuroprotective effect of CD163 in an \u03b1-synuclein mouse model of Parkinson\u2019s disease. NPJ Parkinsons Dis 9: 164. https:\/\/doi.org\/10.1038\/s41531-023-00606-w","DOI":"10.1038\/s41531-023-00606-w"},{"key":"6157_CR35","doi-asserted-by":"publisher","unstructured":"Rajsombath MM, Nam AY, Ericsson M, Nuber S (2019) Female sex and brain-selective estrogen benefit \u03b1-synuclein tetramerization and the PD-like motor syndrome in 3K transgenic mice. J Neurosci 39:7628\u201340.https:\/\/doi.org\/10.1523\/JNEUROSCI.0313-19.2019","DOI":"10.1523\/JNEUROSCI.0313-19.2019"},{"key":"6157_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105853","volume":"209","author":"S Zhou","year":"2021","unstructured":"Zhou S, Liu Y, Jin L, Guo P, Liu Q, Shan J, Luo X, He H et al (2021) Estrogen enhances the cytotoxicity of PARP inhibitors on breast cancer cells through stimulating nitric oxide production. J Steroid Biochem Mol Biol 209:105853. https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105853","journal-title":"J Steroid Biochem Mol Biol"},{"key":"6157_CR37","doi-asserted-by":"publisher","unstructured":"Kim H, Ham S, Lee JY, Jo A, Lee GH, Lee Y-S, Cho M, Shin HM\u00a0et al (2017) Estrogen receptor activation contributes to RNF146 expression and neuroprotection in Parkinson\u2019s disease models. Oncotarget 8:106721\u2013106739.\u00a0https:\/\/doi.org\/10.18632\/oncotarget.21828","DOI":"10.18632\/oncotarget.21828"},{"key":"6157_CR38","doi-asserted-by":"publisher","unstructured":"Subramanya SK, Shekhar S, Kumar DB, Senthil S, Allimuthu D, Luk KC, Thakur P (2025) A novel mouse model of Parkinson\u2019s disease for investigating progressive pathology and neuroprotection. bioRxiv; p.2025.02.13.638053.\u00a0https:\/\/doi.org\/10.1101\/2025.02.13.638053","DOI":"10.1101\/2025.02.13.638053"},{"key":"6157_CR39","doi-asserted-by":"publisher","unstructured":"Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VM, Trojanowski JQ\u00a0et al (2017) Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain. Proc Natl Acad Sci U S A 114:E8284 E8293.\u00a0\u00a0https:\/\/doi.org\/10.1073\/pnas.1710442114","DOI":"10.1073\/pnas.1710442114"},{"key":"6157_CR40","doi-asserted-by":"publisher","unstructured":"Rajan A, Varghese A, Hashardeen SP, Babu AT, Vijayan V, Thakur P (2025) Glycated alpha-synuclein assemblies cause distinct Parkinson\u2019s disease pathogenesis in mice.\u00a0 ACS Chem Neurosci 16:3758\u201373.\u00a0 https:\/\/doi.org\/10.1021\/acschemneuro.5c00428","DOI":"10.1021\/acschemneuro.5c00428"},{"key":"6157_CR41","doi-asserted-by":"publisher","unstructured":"Subramanya SK, Singh D, Thakur P (2025) A one-step mouse model of Parkinson\u2019s disease combining rAAV-\u03b1-synuclein and preformed fibrils of \u03b1-synuclein. Bio-Protoc 15:e5525. https:\/\/doi.org\/10.21769\/BioProtoc.5525","DOI":"10.21769\/BioProtoc.5525"},{"key":"6157_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2020.108775","volume":"341","author":"R Fiker","year":"2020","unstructured":"Fiker R, Kim LH, Molina LA, Chomiak T, Whelan PJ (2020) Visual Gait Lab: a user-friendly approach to gait analysis. J Neurosci Methods 341:108775. https:\/\/doi.org\/10.1016\/j.jneumeth.2020.108775","journal-title":"J Neurosci Methods"},{"key":"6157_CR43","doi-asserted-by":"publisher","unstructured":"Young K, Morrison H (2018) Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ. J Vis Exp JoVE 57648. https:\/\/doi.org\/10.3791\/57648","DOI":"10.3791\/57648"},{"key":"6157_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2023.110025","volume":"402","author":"L Luijerink","year":"2024","unstructured":"Luijerink L, Rodriguez M, Machaalani R (2024) Quantifying GFAP immunohistochemistry in the brain-introduction of the reactivity score (R-score) and how it compares to other methodologies. J Neurosci Methods 402:110025. https:\/\/doi.org\/10.1016\/j.jneumeth.2023.110025","journal-title":"J Neurosci Methods"},{"key":"6157_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008784","volume":"5","author":"V Sanchez-Guajardo","year":"2010","unstructured":"Sanchez-Guajardo V, Febbraro F, Kirik D, Romero-Ramos M (2010) Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson\u2019s disease. PLoS ONE 5:e8784. https:\/\/doi.org\/10.1371\/journal.pone.0008784","journal-title":"PLoS ONE"},{"key":"6157_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-019-01977-2","volume":"138","author":"ZA Sorrentino","year":"2019","unstructured":"Sorrentino ZA, Giasson BI, Chakrabarty P (2019) \u03b1-synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease. Acta Neuropathol 138:1\u201321. https:\/\/doi.org\/10.1007\/s00401-019-01977-2","journal-title":"Acta Neuropathol"},{"key":"6157_CR47","doi-asserted-by":"publisher","first-page":"6571484","DOI":"10.1155\/2020\/6571484","volume":"2020","author":"SS Singh","year":"2020","unstructured":"Singh SS, Rai SN, Birla H, Zahra W, Rathore AS, Dilnashin H, Singh R, Singh SP (2020) Neuroprotective effect of chlorogenic acid on mitochondrial dysfunction-mediated apoptotic death of DA neurons in a Parkinsonian mouse model. Oxid Med Cell Longev 2020:6571484. https:\/\/doi.org\/10.1155\/2020\/6571484","journal-title":"Oxid Med Cell Longev"},{"key":"6157_CR48","doi-asserted-by":"publisher","unstructured":"Faria WCS, da Silva AA, Veggi N, Kawashita NH, de Fran\u00e7a Lemes SA, de Barros WM, da Concei\u00e7ao Cardoso E, Converti A et al (n.d.) Acute and subacute oral toxicity assessment of dry encapsulated and non-encapsulated green coffee fruit extracts. J Food Drug Anal 28:337\u201355. https:\/\/doi.org\/10.38212\/2224-6614.1067","DOI":"10.38212\/2224-6614.1067"},{"key":"6157_CR49","doi-asserted-by":"publisher","unstructured":"Shan S, Tian L, Fang R (2019) Chlorogenic acid exerts beneficial effects in 6-hydroxydopamine-induced neurotoxicity by inhibition of endoplasmic reticulum stress. Med Sci Monit 25:453\u2013459. https:\/\/doi.org\/10.12659\/MSM.911166","DOI":"10.12659\/MSM.911166"},{"key":"6157_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70268","volume":"6","author":"S Liu","year":"2025","unstructured":"Liu S, Liu J, Wang Y, Deng F, Deng Z (2025) Oxidative stress: signaling pathways, biological functions, and disease. MedComm 6:e70268. https:\/\/doi.org\/10.1002\/mco2.70268","journal-title":"MedComm"},{"key":"6157_CR51","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41419-018-0848-7","volume":"9","author":"C Milanese","year":"2018","unstructured":"Milanese C, Cerri S, Ulusoy A, Gornati SV, Plat A, Gabriels S, Blandini F, Di Monte DA et al (2018) Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson\u2019s disease. Cell Death Dis 9:818. https:\/\/doi.org\/10.1038\/s41419-018-0848-7","journal-title":"Cell Death Dis"},{"key":"6157_CR52","doi-asserted-by":"publisher","first-page":"175909142311520","DOI":"10.1177\/17590914231152099","volume":"15","author":"F Zeng","year":"2023","unstructured":"Zeng F, Parker K, Zhan Y, Miller M, Zhu M-Y (2023) Upregulated DNA Damage-Linked Biomarkers in Parkinson\u2019s Disease Model Mice. ASN Neuro 15:17590914231152100. https:\/\/doi.org\/10.1177\/17590914231152099","journal-title":"ASN Neuro"},{"key":"6157_CR53","doi-asserted-by":"crossref","unstructured":"Sharma D, De Falco L, Padavattan S, Rao C, Geifman-Shochat S, Liu C-F, Davey CA (2019) PARP1 exhibits enhanced association and catalytic efficiency with \u03b3H2A.X-nucleosome. Nat Commun 10:5751. https:\/\/doi.org\/10.1038\/s41467-019-13641-0","DOI":"10.1038\/s41467-019-13641-0"},{"key":"6157_CR54","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0140-6736(24)02808-3","volume":"405","author":"N Vijiaratnam","year":"2025","unstructured":"Vijiaratnam N, Girges C, Auld G, McComish R, King A, Skene SS, Hibbert S, Wong A et al (2025) Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson\u2019s disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial. Lancet Lond Engl 405:627\u201336. https:\/\/doi.org\/10.1016\/S0140-6736(24)02808-3","journal-title":"Lancet Lond Engl"},{"key":"6157_CR55","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa2203395","volume":"387","author":"AE Lang","year":"2022","unstructured":"Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N et al (2022) Trial of Cinpanemab in early Parkinson\u2019s disease. N Engl J Med 387:408\u2013420. https:\/\/doi.org\/10.1056\/NEJMoa2203395","journal-title":"N Engl J Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06157-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06157-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:55:55Z","timestamp":1787882155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06157-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6157"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06157-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures were approved by the Institutional Animal Ethics Committee (IAEC) in accordance with the guidelines established by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"863"}}